Effect of Antibiotic Prophylaxis on Surgical Site Infections Following Removal of Orthopedic Implants Used for Treatment of Foot, Ankle, and Lower Leg Fractures | Zendy

Manouk Backes | Zendy; Siem A. Dingemans | Zendy; Marcel G. W. Dijkgraaf | Zendy; Hannah Berg | Zendy; B. van Dijkman | Zendy; J. M. Hoogendoorn | Zendy; Pieter Joosse | Zendy; Ewan Ritchie | Zendy; W.H. Roerdink | Zendy; Judith P. M. Schots | Zendy; Nico L. Sosef | Zendy; Ingrid J. B. Spijkerman | Zendy; Bas A Twigt | Zendy; A.H. van der Veen | Zendy; Ruben N. van Veen | Zendy; Jefrey Vermeulen | Zendy; Dagmar I. Vos | Zendy; Jasper Winkelhagen | Zendy; J. Carel Goslings | Zendy; Tim Schepers | Zendy

Open Access

Effect of Antibiotic Prophylaxis on Surgical Site Infections Following Removal of Orthopedic Implants Used for Treatment of Foot, Ankle, and Lower Leg Fractures

Author(s) -

Manouk Backes,

Siem A. Dingemans,

Marcel G. W. Dijkgraaf,

Hannah Berg,

B. van Dijkman,

J. M. Hoogendoorn,

Pieter Joosse,

Ewan Ritchie,

W.H. Roerdink,

Judith P. M. Schots,

Nico L. Sosef,

Ingrid J. B. Spijkerman,

Bas A Twigt,

A.H. van der Veen,

Ruben N. van Veen,

Jefrey Vermeulen,

Dagmar I. Vos,

Jasper Winkelhagen,

J. Carel Goslings,

Tim Schepers

Publication year - 2017

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2017.19343

Subject(s) - medicine , orthopedic surgery , cefazolin , surgery , antibiotic prophylaxis , interquartile range , randomized controlled trial , antibiotics , microbiology and biotechnology , biology

Following clean (class I, not contaminated) surgical procedures, the rate of surgical site infection (SSI) should be less than approximately 2%. However, an infection rate of 12.2% has been reported following removal of orthopedic implants used for treatment of fractures below the knee.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research